Potential Mechanisms of Interferon-α Induced Autoimmunity

References

• Barnes, B., Lubyova, B. and Pitha, P.M. (2002) "On the role of 1RF in host defense", J. Interferon Cytokine Res. 22, 59–71
   PubMed Web of Science ®Google Scholar
• Civas, A., Island, ML., Genin, P., Morin, P. and Navarro, S. (2002) "Regulation of virus-induced interferon—A genes", Biochimie 84, 643–654
   PubMed Web of Science ®Google Scholar
• Darnell, Jr., J.E., Kerr, I.M. and Stark, G.R. (1994) "Jak-STAT pathways and transcriptional activation in response to 1FN5 and other extracellular signaling proteins", Science 264, 1415–1421
   PubMed Web of Science ®Google Scholar
• Stark, G.R., Kerr, I.M., Williams, BR., Silverman, R.H. and Schreiber, RD. (1998) "How cells respond to interferons", Annu. Rev. Biochem. 67, 227–264
   PubMed Web of Science ®Google Scholar
• Zhou, A., Paranjape, J.M., Der, S.D., Williams, BR. and Silverman, R.H. (1999) "Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways", Virology 258, 435–440
   PubMed Web of Science ®Google Scholar
• Levy, D.E., Marie, I. and Prakash, A. (2003) "Ringing the interferon alarm: differential regulation of gene expression at the interface between innate and adaptive immunity", Curr. Opin. Immunol. 15, 52–58
   PubMed Web of Science ®Google Scholar
• Taniguchi, T. and Takaoka, A. (2002) "The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the 1RF family of transcription factors", Curr. Opin. Immunol. 14, 111–116
   PubMed Web of Science ®Google Scholar
• Der, S.D., Thou, A., Williams, B.R. and Silverman, R.H. (1998) "Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays", Proc. Nati Acad. Sci. USA 95, 15623–15628
   PubMed Web of Science ®Google Scholar
• Harle, P., Cull, V, Agbaga, M.P., et al. (2002) "Differential effect of murine alpha/beta interferon transgenes on antagonization of herpes simplex virus type 1 replication", J. Virol. 76, 6558–6567
   PubMed Web of Science ®Google Scholar
• Bogdan, C. (2000) "The function of type I interferons in antimicrobial immunity", Curr. Opin. Immunol. 12, 419–424
   PubMed Web of Science ®Google Scholar
• Biron, CA. (2001) "Interferons alpha and beta as immune regulators—a new look", Immunity 14, 661–664
   PubMed Web of Science ®Google Scholar
• Kelsall, B.L., Biron, CA., Sharma, O. and Kaye, P.M. (2002) "Dendritic cells at the host-pathogen interface", Nat. Immunol. 3, 699–702
   PubMed Web of Science ®Google Scholar
• Le Bon, A. and Tough, D.F. (2002) "Links between innate and adaptive immunity via type I interferon", Curr. Opin. Immunol. 14, 432–436
   PubMed Web of Science ®Google Scholar
• Luft, T., Pang, K.C., Thomas, E., et al. (1998) "Type I IFNs enhance the terminal differentiation of dendritic cells", J. Immunol. 161, 1947–1953
   PubMed Web of Science ®Google Scholar
• Santini, S.M., Lapenta, C., Logozzi, M., et al. (2000) "Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice", J. Exp. Med. 191, 1777–1788
   PubMed Web of Science ®Google Scholar
• Trinchieri, G. (2003) "Interleukin-12 and the regulation of innate resistance and adaptive immunity", Nat. Rev. Immunol. 3, 133–146
   PubMed Web of Science ®Google Scholar
• Le Bon, A., Schiavoni, G., D'Agostino, G., Gresser, I., Belardelli, F. and Tough, D.F. (2001) "Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo", Immunity 14, 461–470
   PubMed Web of Science ®Google Scholar
• Litinskiy, MB., Nardelli, B., Hilbert, D.M., et al. (2002) "DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL", Nat. Immunol. 3, 822–829
   PubMed Web of Science ®Google Scholar
• Siegal, FR, Kadowaki, N., Shodell, M., et al. (1999) "The nature of the principal type 1 interferon-producing cells in human blood", Science 284, 1835–1837
   PubMed Web of Science ®Google Scholar
• Sharara, Al., Perkins, D.J., Misukonis, MA., Chan, S.U., Dominitz, J.A. and Weinberg, J.B. (1997) "Interferon (IFN)-alpha activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: possible relationship of induced N052 to the anti-hepatitis C effects of IFN-alpha in vivo", J. Exp. Med. 186, 1495–1502
   PubMed Web of Science ®Google Scholar
• Marrack, P., Kappler, J. and Mitchell, T. (1999) "Type I interferons keep activated T cells alive", J. Exp. Med. 189, 521–530
   PubMed Web of Science ®Google Scholar
• Anderson, M.S. (2002) "Autoimmune endocrine disease", Curr. Opin. Immunol. 14, 760–764
   PubMed Web of Science ®Google Scholar
• Hardin, LA. (2003) "Directing autoimmunity to nucleoprotein particles: the impact of dendritic cells and interferon alpha in lupus", J. Exp. Med. 197, 681–685
   PubMed Web of Science ®Google Scholar
• Jacobson, DL., Gange, S.J., Rose, N.R. and Graham, N.M. (1997) "Epidemiology and estimated population burden of selected autoimmune diseases in the United States", Clin. Immunol. Immunopathol. 84, 223–243
   PubMedGoogle Scholar
• Ioannou, Y. and Isenberg, D.A. (2000) "Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy", Arthritis Rheum. 43, 1431–1442
   PubMed Web of Science ®Google Scholar
• Todd, J.A. (1999) "From genome to aetiology in a multifactorial disease, type 1 diabetes", Bioessays 21, 164–174
   PubMed Web of Science ®Google Scholar
• Devendra, D. and Eisenbarth, G.S. (2003) "17. Immunologic endocrine disorders", J. Allergy Clin. Immunol. 111, 5624—S636
   Google Scholar
• Dahlman, I., Eaves, LA., Kosoy, R., et al. (2002) "Parameters for reliable results in genetic association studies in common disease", Nat. Genet. 30, 149–150
   PubMed Web of Science ®Google Scholar
• Ueda, H., Howson, J.M., Esposito, L, et al. (2003) "Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease", Nature
   Google Scholar
• Cordell, H.J., Todd, J.A., Hill, N.J., et al. (2001) "Statistical modeling of interlocus interactions in a complex disease: rejection of the multiplicative model of epistasis in type 1 diabetes", Genetics 158, 357–367
   PubMed Web of Science ®Google Scholar
• Wakeland, E.K., Liu, K., Graham, R.R. and Behrens, T.W. (2001) "Delineating the genetic basis of systemic lupus erythematosus", Immunity 15, 397–408
   PubMed Web of Science ®Google Scholar
• Jaeckel, E., Maims, M. and Von Herrath, M. (2002) "Viruses and diabetes", Ann. N. Y Acad. Sci. 958, 7–25
   PubMed Web of Science ®Google Scholar
• Murakami, M., Iriuchijima, T. and Mori, M. (1995) "Diabetes mellitus and interferon-alpha therapy", Ann. Intern. Med. 123, 318
   PubMed Web of Science ®Google Scholar
• Blanco, P., Palucka, A.K., Gill, M., Pascual, V. and Banchereau, J. (2001) "Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus", Science 294, 1540–1543
   PubMed Web of Science ®Google Scholar
• Fossati-Jimack, L., Ioan-Facsinay, A., Reininger, L., et al. (2000) "Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III", J. Exp. Med. 191, 1293–1302
   PubMed Web of Science ®Google Scholar
• Bennett, L., Palucka, A.K., Arce, E., et al. (2003) "Interferon and granulopoiesis signatures in systemic lupus erythematosus blood", J. Exp. Med. 197, 711 —723
   Web of Science ®Google Scholar
• Stewart, TA., Hultgren, B., Huang, X., Pitts-Meek, S., Hully, J. and MacLachlan, N.J. (1993) "Induction of type I diabetes by interferon-alpha in transgenic mice", Science 260, 1942–1946
   PubMed Web of Science ®Google Scholar
• Moriyama, H., Wen, L., Abiru, N., et al. (2002) "Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic—polycytidylic acid) and an insulin self-peptide", Proc. Natl Acad. Sci. USA 99, 5539–5544
   PubMed Web of Science ®Google Scholar
• Chehadeh, W., Weill, J., Vantyghem, MC., et al. (2000) "Increased level of interferon-alpha in blood of patients with insulin-dependent diabetes mellitus: relationship with coxsackievirus B infection", J. Infect. Dis. 181, 1929–1939
   PubMed Web of Science ®Google Scholar
• Foulis, A.K., Farquharson, M.A. and Meager, A. (1987) "Immunoreactive alpha-interferon in insulin-secreting beta cells in type 1 diabetes mellitus", Lancet 2, 1423–1427
   PubMed Web of Science ®Google Scholar
• Huang, X., Yuang, J., Goddard, A., et al. (1995) "Interferon expression in the pancreases of patients with type I diabetes", Diabetes 44, 658–664
   PubMed Web of Science ®Google Scholar
• Bonnevie-Nielsen, V., Martensen, P.M., Justesen, J., et al. (2000) "The antiviral 2',5'-oligoadenylate synthetase is persistently activated in type 1 diabetes", Clin. Immunol. 96, 11–18
   PubMed Web of Science ®Google Scholar
• Herman, A., Kappler, J.W., Marrack, P. and Pullen, A.M. (1991) "Superantigens: mechanism of T-cell stimulation and role in immune responses", Annu. Rev. Immunol. 9, 745–772
   PubMed Web of Science ®Google Scholar
• Acha-Orbea, H. and MacDonald, H.R. (1995) "Superantigens of mouse mammary tumor virus", Annu. Rev. Immunol. 13, 459–486
   PubMed Web of Science ®Google Scholar
• Sundberg, E.J., Li, Y. and Mariuzza, R.A. (2002) "So many ways of getting in the way: diversity in the molecular architecture of superantigen-dependent T-cell signaling complexes", Curr. Opin. Immunol. 14, 36–44
   PubMed Web of Science ®Google Scholar
• Conrad, B., Weidmann, E., Trucco, G., et al. (1994) "Evidence for superantigen involvement in insulin-dependent diabetes mellitus aetiology", Nature 371, 351–355
   PubMed Web of Science ®Google Scholar
• Conrad, B., Weissmahr, RN., Boni, J., Arcari, R., Schupbach, J. and Mach, B. (1997) "A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes", Cell 90, 303–313
   PubMed Web of Science ®Google Scholar
• Stauffer, Y, Marguerat, S., Meylan, F., et al. (2001) "Interferon-alpha-induced endogenous superantigen. A model linking environ-ment and autoimmunity", Immunity 15, 591–601
   PubMed Web of Science ®Google Scholar
• Sutkowski, N., Conrad, B., Thorley-Lawson, D.A. and Huber, B.T. (2001) "Epstein—Barr virus transactivates the human endogenous retrovirus HERV- K18 that encodes a superantigen", Immunity 15, 579–589
   PubMed Web of Science ®Google Scholar
• Renno, T. and Acha-Orbea, H. (1996) "Superantigens in autoimmune diseases: still more shades of gray", Immunol. Rev. 154, 175–191
   PubMed Web of Science ®Google Scholar
• Luppi, P., Zanone, M.M., Hyoty, H., et al. (2000) "Restricted TCR V beta gene expression and enterovirus infection in type I diabetes: a pilot study", Diabetologia 43, 1484–1497
   PubMed Web of Science ®Google Scholar
• Torres, B.A., Perrin, G.Q., Mujtaba, M.G., Subramaniam, P.S., Anderson, A.K. and Johnson, H.M. (2002) "Superantigen enhancement of specific immunity: antibody production and signaling pathways", J. Immunol. 169, 2907–2914
   PubMed Web of Science ®Google Scholar
• Betterle, C., Fabris, P., Zanchetta, R., et al. (2000) "Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection", Diabetes Care 23, 1177–1181
   PubMed Web of Science ®Google Scholar